The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Oncology & Cancer

SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
Basic & Discovery Research

SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

MAY 8, 2023
FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013
Clinical & Manufacturing

FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013

APR 28, 2023
Engineered bacteria find tumors, then alert the authorities
Basic & Discovery Research

Engineered bacteria find tumors, then alert the authorities

MAR 13, 2023
Colorectal cancer surgery: Gut microbiota helps healing
Oncology & Cancer

Colorectal cancer surgery: Gut microbiota helps healing

MAR 8, 2023
Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform
Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

FEB 10, 2023
MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers
Oncology & Cancer

MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

FEB 2, 2023
Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection
Oncology & Cancer

Micronoma receives FDA breakthrough device designation for novel liquid biopsy assay for lung carcinoma detection

JAN 12, 2023
Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment
Basic & Discovery Research

Researchers find tumor microbiome interactions may identify new approaches for pancreatic cancer treatment

OCT 14, 2022
First-ever mycobiome atlas describes associations between cancers and fungi
Basic & Discovery Research

First-ever mycobiome atlas describes associations between cancers and fungi

OCT 3, 2022
Microba Accelerates Cancer Program with New Leads
Oncology & Cancer

Microba Accelerates Cancer Program with New Leads

MAY 5, 2022
A new photoactive viral vector for anti-cancer therapy has been developed
Genetically Modified Organisms & Synthetic Biology

A new photoactive viral vector for anti-cancer therapy has been developed

MAR 15, 2022